Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis

Area of Science:

• Pediatrics
• Respiratory Medicine
• Clinical Trials

Background:

• Bronchiolitis is a common respiratory infection in infants.
• Post-bronchiolitis wheezing can be a persistent issue.
• The efficacy of corticosteroids like prednisolone in treating bronchiolitis is debated.

Purpose of the Study:

• To evaluate the long-term and short-term effects of prednisolone on hospitalized infants diagnosed with bronchiolitis.
• To determine if prednisolone impacts the prevalence of post-bronchiolitis wheezing.
• To assess the influence of prednisolone on the acute phase of bronchiolitis during hospitalization.

Main Methods:

• A randomized controlled trial was conducted involving hospitalized infants with bronchiolitis.
• Patients were assigned to receive either prednisolone plus standard care or standard care alone.
• Primary endpoint: prevalence of post-bronchiolitis wheezing at 1, 3, 6, and 12 months post-discharge. Secondary endpoints included length of stay, oxygen therapy duration, and time to clinical improvement.

Main Results:

• No significant differences in post-bronchiolitis wheezing rates were observed between the prednisolone and control groups at any follow-up point (1, 3, 6, 12 months).
• Prednisolone did not significantly reduce the length of hospital stay, duration of oxygen therapy, or time to clinical resolution compared to standard care alone.
• Statistical analysis showed no discernible benefit of prednisolone in managing acute bronchiolitis or preventing subsequent wheezing.

Conclusions:

• Prednisolone is ineffective in reducing the prevalence of post-bronchiolitis wheezing in hospitalized infants.
• The administration of prednisolone does not improve the acute course of illness in infants with bronchiolitis.
• Current evidence suggests prednisolone should not be routinely used for hospitalized infants with bronchiolitis.